CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for HANS BIOMED CORP is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

HANS BIOMED CORP
7, Jeongui-ro 8-gil, Songpa-gu
Phone: +82 24662266p:+82 24662266 SEOUL, 05836  South Korea Ticker: 042520042520
Business Summary
HansBiomed Co.,Ltd is a Korea-based company engaged in the biotechnology industry. The Company mainly provides three categories of products: skin-implant materials, bone-implant materials and silicone products. Its skin-implant materials are used for burn treatment and skin graft under the brand names of SureDerm, BellaGen and GPS. Its bone-implant materials include allogeneic bones, xenogenous bones and synthetic bones used in dentistry, orthopedic and others, which are under the brand names of SureFuse, ExFuse and SureOss. Its silicone products are used for treatments of scars and for breast implant and others, which are under the brand names of BellaGel and Scar Clinic. In addition, it provides hair transplanters and others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/20249/30/2023Yes----

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Director Geun YeongKim 59 7/30/2021 12/29/2014
Internal Auditor, Director Chang HuiKim 56
Assistant Managing Director Jong HunLee 43 12/1/2019 12/1/2019
3 additional Officers and Directors records available in full report.

Business Names
Business Name
042520
HANS BIOMED CORPORATION
HansBiomed USA, Inc.

General Information
Number of Employees: 105 (As of 12/31/2015)
Outstanding Shares: 12,986,979 (As of 6/30/2024)
Shareholders: 17,231
Stock Exchange: KDQ
Fax Number: +82 24631554


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024